Aldergrove, Canada

Wen Yang

This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Anormed, Inc., Genzyme Corporation. Active years: 2002-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen Yang. Retrieved from https://idiyas.com/inventor/wen-yang-ovxtwkic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 50.0


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 37(Granted Patents)


Location History:

  • Langley, CA (2002)
  • Aldergrove, CA (2006 - 2010)

Company Filing History:


Years Active: 2002-2010

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Wen Yang

Introduction

Wen Yang, a talented inventor based in Aldergrove, CA, has made significant contributions to the field of biomedical innovations. With a remarkable portfolio that includes six patents, she has dedicated her career to advancing scientific knowledge and developing therapeutic solutions. Her groundbreaking research focuses on chemokine receptor binding compounds, particularly in relation to HIV infection.

Latest Patents

Wen's latest patents revolve around chemokine receptor binding compounds. These innovations include pharmaceutical compositions that target modulators of chemokine receptor activity, with an emphasis on CCR5. The significance of her work lies in the protective effects these compounds demonstrate against the infection of target cells by the human immunodeficiency virus (HIV). This advancement holds promise for new treatment pathways and enhances our understanding of antiviral therapies.

Career Highlights

Throughout her illustrious career, Wen has been associated with notable companies such as Anormed, Inc. and Genzyme Corporation. Her experience within these organizations has contributed to her expertise in developing innovative pharmaceutical solutions. Wen’s dedication to research and development has set her apart as a leader in her field.

Collaborations

Wen has had the privilege of collaborating with esteemed colleagues, including Renato Skerlj and Gary James Bridger. These partnerships have not only enriched her professional journey but have also fostered a collaborative environment conducive to innovation and discovery in the biopharmaceutical sector.

Conclusion

Wen Yang's contributions to biomedical innovation, particularly her developments in chemokine receptor binding compounds, position her as a key figure in the ongoing fight against HIV. Her work exemplifies the impact that dedicated inventors can have on public health through innovative research and collaborative efforts. As she continues her journey in the realm of inventions, the scientific community eagerly anticipates her future contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…